Inflarx Gmbh
Clinical trials sponsored by Inflarx Gmbh, explained in plain language.
-
Promising ulcer drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called vilobelimab for people with pyoderma gangrenosum, a rare condition that causes deep, painful skin ulcers. The trial aimed to see if the drug could completely close these ulcers better than a placebo. However, the study was stopped early, so the res…
Phase: PHASE3 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New pill aims to calm stubborn skin flare-ups
Symptom relief TerminatedThis study tested an experimental oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). Participants took the drug daily for 28 days, and researchers monitored safety and h…
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Symptom relief
Last updated May 26, 2026 12:03 UTC